Evotec SE (EVO) Goodwill & Intangibles (2009 - 2026)
Evotec SE (EVO) posted Goodwill & Intangibles of $357553.9 for Q1 2026, down 99.89% sequentially from $317.4 million in Q4 2025, and up 10.26% YoY from $324277.0 in Q1 2025.
Evotec SE (EVO) Goodwill & Intangibles (2009 - 2026) Analysis & Trends
Evotec SE has reported Goodwill & Intangibles for 10 years, with the latest figure at $357553.9 in Q1 2026.
- Quarterly Goodwill & Intangibles rose 10.26% year-over-year to $357553.9 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $357553.9 (up 10.26% YoY) and the FY2025 annual result came in at $317.4 million, down 49.84% from the prior year.
- Goodwill & Intangibles declined to $357553.9 in Q1 2026 per EVO's latest filing, from $317.4 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $632.8 million in Q4 2024 and troughed at $306669.7 in Q3 2022.
- A 5-year average of $130.9 million and a median of $347907.5 in 2025 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2024 and 2025: Goodwill & Intangibles soared 102.04% in 2024, then sank 49.84% in 2025.
- Over 5 years, Goodwill & Intangibles stood at $304.7 million in 2022, then climbed by 2.79% to $313.2 million in 2023, then jumped by 102.04% to $632.8 million in 2024, then tumbled by 49.84% to $317.4 million in 2025, then sank by 99.89% to $357553.9 in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $357553.9, $317.4 million, and $351366.5 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Evotec SE | 687.23 Mn | 686.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 357,553.92 |
| Dec 31, 2025 | 317.40 Mn |
| Sep 30, 2025 | 351,366.52 |
| Jun 30, 2025 | 344,448.54 |
| Mar 31, 2025 | 324,277.04 |
| Dec 31, 2024 | 632.77 Mn |
| Sep 30, 2024 | 324,925.81 |
| Mar 31, 2024 | 320,604.91 |
| Dec 31, 2023 | 313.19 Mn |
| Dec 31, 2022 | 304.68 Mn |
| Sep 30, 2022 | 306,669.66 |
| Mar 31, 2022 | 321,893.19 |
| Dec 31, 2021 | 329.94 Mn |
| Sep 30, 2021 | 338,379.99 |
| Dec 31, 2020 | 411.82 Mn |
| Dec 31, 2019 | 412.77 Mn |
| Sep 30, 2010 | 97,278.02 |
| Jun 30, 2010 | 2,182.52 |
| Mar 31, 2010 | 2,370.62 |
| Dec 31, 2009 | 67,290.35 |